Past Event
Rewriting the Nuclear Story: U.S. Cultural Audit Research Findings
2:30PM EDT
Leader of World’s Largest Biotech Advocacy Organization, Michelle McMurry-Heath, Joins NTI’s Board of Directors
A global leader in science policy with a background in biosecurity, McMurry-Heath is a medical doctor and immunologist whose career spans government, the pharmaceutical industry, and biotechnology.
Article
Michelle McMurry-Heath
Multi-Track Diplomacy Explained
NTI’s 2021 Annual Report: 20 Years of Building a Safer World
The 2021 Annual Report illustrates how NTI makes an impact, details the organization’s financials, and thanks our generous supporters.
Russia’s Kinzhal Hypersonic Missile: A Game-Changing Weapon or a Distraction?
Jaime Yassif, Ph.D., Named Vice President, Global Biological Policy and Programs at NTI
Yassif will oversee NTI | bio’s work to reduce global catastrophic biological risks, strengthen biosecurity and pandemic preparedness, and build accountability for global health security progress.
Page
Consultant for Monitoring and Evaluation Framework Development – Global Biological Policy and Programs (NTI | bio)
What is the A/CPPNM and Why is it Important?
This week in Vienna, experts from the Nuclear Threat Initiative are joining government officials and experts from international organizations, non-governmental organizations, academia, and the nuclear industry for the first-ever review of the only legally binding treaty on nuclear security—the amended Convention on the Physical Protection of Nuclear Materials (A/CPPNM).
Resource Collection
2022 Nuclear Posture Review Resources Page
A resource collection for the 2022 Nuclear posture review